2020 Healthcare & Pharmaceutical Awards

GHP / 2020 Healthcare & Pharmaceutical Awards 43 , Best CRO & Biofilm/ Antibiofilm Centre 2020 5DHealth Protection Group is a leading global customer focused organisation at the forefront of contract microbiology and scientific testing, underpinned by 28 years’ experience of biofilm research and antibiofilm innovations. Having recently been recognised in GHP’s Healthcare and Pharmaceutical Awards 2020, we profiled the organisation to discover how they became one of the best CRO& Biofilm/Antibiofilm centres in the industry today. The Group is UKAS accredited and certified to ISO 9001, ISO 13485 and ISO 17025. As well as the standard tests, it also offers support and guidance on defining which tests are the most suitable to specific requirements, and can construct a strategic testing schedule to provide clients with the evidence and results that will empower their business. Steven Percival, CEO, tells us more about 5D Health Protection Group and its core offering. “Here at 5D, our mission is to develop strategic alliances with our customers by supporting them in the global protection and enhancement of public health through the provision of contract scientific testing and innovation services,” he explains. “We partner with our customers to transform their organisations. Providing world class scientific support to our customers, generating results that matter to them. In addition to this, we also help to turn our customers’ needs and requirements into reality.” The firm’s vision is to use its expertise for the good of all by applying thorough and proven scientific and research principles within its specialist areas in order to lead discovery, drive understanding and advance the knowledge of itself, its partners and the wider community. “We work to take this knowledge and understanding and harness it Sep20541 to innovate and enhance solutions within products, companies and the wider world,” Steven states. As a ‘one stop shop for all microbiology and scientific testing’, 5D also provides on-going advice and support to its customers during their development of technical files and design dossiers for CE marks and 510k submissions. “From the inception of a project it is our in-house expertise that adds significant value to a customer’s innovation and product development process. We help to ensure that the project is delivered cost effectively, on scope and on time. 5D represents the ideal partnering organisation for you innovation and R&D needs. “Outsourcing innovation and R&D to 5D has been shown to significantly help to reduce costs, save time and create value for our partners. 5D is an expert organisation with world-class knowledge and skills in antimicrobial and antibiofilm research and innovation. We support spin-off, SME and multinational organisations.” To ensure that it remains at the top of its game, 5D constantly strives to advance the skills of its employees and improve on its existing scientific service offerings. “With our world-class facilities and our extensive academic, public health and industrial experience, we ensure that we are always at the forefront of research and discovery in many industrial sectors. As a leading provider of scientific research services, we help companies develop new hypotheses, products and also services which are often not part of their core expertise.” 5D has a number of granted patents and patents pending. The granted patents include its next generation antibiofilm and antimicrobial metal-EDTA compound/complex for combatting biofilms and/or treating medical devices related infections, including acute and chronic wounds. “The 5D antibiofilm complexes comprises EDTA with the addition of different metal ions in conjunction with non-metal antimicrobials and surfactants,” explains Steven. “Metal ions, could include Ag, Al, Au, Ba, Ti, and Zn ions to name a few. The metal-EDTA complex and non- metal antimicrobial combination may exhibit any one or more of anti-microbial, anti-biofilm and anti-inflammatory activities in use and may increase the susceptibility of a biofilm and the microorganisms within biofilms to attack by anti-microbial agents, helping to remove and sanitise the biofilm. Uses of the metal- EDTA and non-metal antimicrobial complex combination can be used as a medicament to sanitise and/ or substantially remove a biofilm from a substrate. “In addition, we have other patents filed in the area of antibiofilm technologies that can be used in a wide range of industries including medical devices, wound dressings, dentistry, food processing to name but a few. Further patents we have filed include the use of biosensor and diagnostic patents to study changes within medical devices and patients.” Contact Details: Contact: Steven Percival Company: 5D Health Protection Group Ltd Web Address: www.5DHPG.com 5D Health Protection Group Ltd